Literature DB >> 12224691

Pemphigus vulgaris with oral involvement: evaluation of two different systemic corticosteroid therapeutic protocols.

F Femiano1, F Gombos, C Scully.   

Abstract

BACKGROUND: Pemphigus vulgaris is a potentially life-threatening disease characterized by cutaneous and mucosal blistering. Systemic corticosteroids remain the mainstay of therapy, transforming an invariably fatal disease into one with a mortality that is now less than 10%. Nevertheless, oral lesions are often recalcitrant and corticosteroid therapy can provoke adverse effects.
OBJECTIVE: To determine whether two different regimens of systemic corticosteroid therapy based on prednisone gave different benefits.
METHOD: We examined two different regimens of systemic corticosteroid therapy based on prednisone in an open study. Ten patients (group A) were treated with systemic corticosteroids, in a therapeutic protocol made up of orally administered prednisone. Ten matched patients (group B) were treated with systemic corticosteroids alternating a pulse of intravenous betamethasone with orally administered prednisone. RESULTS AND
CONCLUSIONS: The pulse protocol appeared to have some advantages both in a shorter time to resolution of symptoms and oral lesions, and in terms of minor adverse effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12224691     DOI: 10.1046/j.1468-3083.2002.00461.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  6 in total

1.  Pemphigus vulgaris presented with cheilitis.

Authors:  Zaheer Abbas; Zahra Safaie Naraghi; Elham Behrangi
Journal:  Case Rep Dermatol Med       Date:  2014-09-25

Review 2.  Pemphigus: Current and Future Therapeutic Strategies.

Authors:  Dario Didona; Roberto Maglie; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

3.  Oral Pemphigus Vulgaris Treatment with Corticosteroids and Azathioprine: A Long-Term Study in Shiraz, Iran.

Authors:  Mehdy Davarmanesh; Maryam Zahed; Asma Sookhakian; Sina Jehbez
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-17       Impact factor: 2.650

Review 4.  Management of pemphigus vulgaris: challenges and solutions.

Authors:  Stamatis Gregoriou; Ourania Efthymiou; Christina Stefanaki; Dimitris Rigopoulos
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-10-21

Review 5.  Management of Pemphigus Vulgaris.

Authors:  Mimansa Cholera; Nita Chainani-Wu
Journal:  Adv Ther       Date:  2016-06-10       Impact factor: 3.845

Review 6.  Emerging treatment options for the management of pemphigus vulgaris.

Authors:  Khalaf Kridin
Journal:  Ther Clin Risk Manag       Date:  2018-04-27       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.